# Ocular Therapeutix, Inc: funding, H-1B, 10-K (November 2026)

Registers read on November 19, 2026.

Ocular Therapeutix, Inc (Massachusetts) appears in 3 public registers SpecStream reads: 7 Form D filings, 17 certified H-1B and PERM cases and 5 SEC annual and quarterly reports; the newest record is dated August 21, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 3
- Newest record: August 21, 2026
- State: Massachusetts

## Form D filings (SEC)

7 Form D filings, newest March 18, 2019.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/ocular-therapeutix-inc-1393434) | March 18, 2019 | $37.5 million sold of $37.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1393434/000139343419000001/0001393434-19-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/ocular-therapeutix-inc-1393434) | June 10, 2013 | $8.5 million sold of $8.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1393434/000139343413000001/0001393434-13-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/ocular-therapeutix-inc-1393434) | February 8, 2011 | $14 million sold of $14 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1393434/000139343411000003/0001393434-11-000003-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/ocular-therapeutix-inc-1393434) | January 12, 2011 | $21 million sold of $21 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1393434/000139343411000002/0001393434-11-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/ocular-therapeutix-inc-1393434) | July 2, 2009 | $15 million sold of $15 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1393434/000139343409000007/0001393434-09-000007-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/ocular-therapeutix-inc-1393434) | July 1, 2009 | $6 million sold of $6 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1393434/000139343409000006/0001393434-09-000006-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/ocular-therapeutix-inc-1393434) | July 1, 2009 | $1.1 million sold of $1.1 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1393434/000139343409000005/0001393434-09-000005-index.htm) |

- [OCULAR THERAPEUTIX, INC](https://specstream.ai/data/form-d/company/ocular-therapeutix-inc-1393434)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1393434&type=D)

## H-1B and PERM certifications (Department of Labor)

17 certified H-1B and PERM cases, newest August 21, 2026.

- EIN: 20-5560161

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Senior Manager, Regulatory Affairs](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | August 21, 2026 | PERM, 1 case, $175 thousand offered | [dol.gov](https://www.dol.gov/media/PERM_Disclosure_Data_FY2026_Q4.xlsx) |
| [Senior Computer Systems Validation Engineer](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | May 18, 2026 | H-1B, 1 case, $135 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q3.xlsx) |
| [Engineer III, Process Development](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | May 5, 2026 | PERM, 1 case, $118.6 thousand offered | [dol.gov](https://www.dol.gov/media/PERM_Disclosure_Data_FY2026_Q4.xlsx) |
| [Clinical Scientist](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | March 13, 2026 | H-1B, 2 cases, $104 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q2.xlsx) |
| [Sr. Manager, Medical and Scientific Publications](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | January 20, 2026 | H-1B, 1 case, $179 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q2.xlsx) |
| [Senior Manager, Regulatory Affairs](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | January 15, 2026 | H-1B, 2 cases, $176.5 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q2.xlsx) |
| [Senior Engineer](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | July 11, 2025 | H-1B, 1 case, $140 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2025_Q4.xlsx) |
| [Manager, QA Compliance](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | June 23, 2025 | H-1B, 1 case, $140 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2025_Q3.xlsx) |
| [Quality Analyst 1 “ Microbiology](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | May 16, 2025 | H-1B, 1 case, $62.2 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2025_Q3.xlsx) |
| [Senior Manager, Strategic Sourcing](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161) | April 11, 2025 | H-1B, 1 case, $142 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2025_Q3.xlsx) |

- [Ocular Therapeutix, Inc.](https://specstream.ai/data/hiring/employer/ocular-therapeutix-inc-205560161)

## Public company financials (SEC)

5 SEC annual and quarterly reports, newest February 5, 2026.

- SEC central index key (CIK): 1393434
- Industry: SIC 2834, Pharmaceutical preparations
- Filer category: Large accelerated filer

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [10-K filed February 5, 2026](https://specstream.ai/data/public-companies/company/1393434-ocular-therapeutix-inc) | February 5, 2026 | Revenue $52 million | [sec.gov](https://www.sec.gov/Archives/edgar/data/1393434/000110465926010664/0001104659-26-010664-index.htm) |

- [Ocular Therapeutix, Inc](https://specstream.ai/data/public-companies/company/1393434-ocular-therapeutix-inc)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (Massachusetts), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Massachusetts

- [Pharmaceutical companies in Massachusetts, United States](https://specstream.ai/data/businesses/pharmaceutical-companies/massachusetts-united-states)
- [Medical billing companies in Massachusetts, United States](https://specstream.ai/data/businesses/medical-billing-companies/massachusetts-united-states)
- [Kitchen remodelers in Massachusetts, United States](https://specstream.ai/data/businesses/kitchen-remodelers/massachusetts-united-states)
- [HVAC suppliers in Massachusetts, United States](https://specstream.ai/data/businesses/hvac-suppliers/massachusetts-united-states)
- [Garage door companies in Massachusetts, United States](https://specstream.ai/data/businesses/garage-door-companies/massachusetts-united-states)
- [Energy companies in Massachusetts, United States](https://specstream.ai/data/businesses/energy-companies/massachusetts-united-states)
